Multiple Myeloma

Showing NaN - NaN of 114

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in United States (P-BCMA-101 CAR-T cells, Rimiducid)

Terminated
  • Multiple Myeloma
  • Gilbert, Arizona
  • +15 more
May 17, 2022

Multiple Myeloma Trial in Chicago, Milwaukee (Bortezomib, Isatuximab, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Venetoclax)

Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +39 more
Mar 2, 2022

Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

Recruiting
  • Multiple Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 25, 2022

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)

Completed
  • Multiple Myeloma
  • Whittier, California
  • +19 more
Feb 2, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Canada, United States (Pomalidomide, Carfilzomib, dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +4 more
Jan 7, 2022

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma Trial in Sweden, United States (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +8 more
Nov 23, 2021

Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

Terminated
  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Scottsdale, Arizona
  • +18 more
Nov 15, 2021

Multiple Myeloma Trial in Chicago, Evanston, Ann Arbor (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Nov 12, 2021

Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)

Recruiting
  • Myeloma
  • Multiple Myeloma
  • Chicago, Illinois
    The University of Chicago
Sep 15, 2021

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Active, not recruiting
  • Acute Leukemia
  • +3 more
  • cytogenetic analysis
  • La Jolla, California
  • +136 more
Aug 16, 2021

Multiple Myeloma Trial in Germany, United States (LBH589)

Terminated
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +28 more
Jun 22, 2021

Multiple Myeloma Trial in Chicago, Detroit, Poznan (Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Jun 29, 2021

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who

Recruiting
  • Multiple Myeloma
  • +3 more
  • EndoPAT
  • +4 more
  • Chicago, Illinois
    University of Chicago
Jun 7, 2021

Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021

Multiple Myeloma Trial in United States (Oprozomib, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Huntsville, Alabama
  • +13 more
Mar 2, 2021

Multiple Myeloma Trial in United States (bb21217)

Active, not recruiting
  • Multiple Myeloma
  • bb21217
  • San Francisco, California
  • +10 more
Mar 17, 2021

Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin

Completed
  • Leukemia
  • +3 more
  • Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
  • +4 more
  • Chicago, Illinois
    The University of Chicago
Jan 8, 2021

Connect® MM- The Multiple Myeloma Disease Registry

Active, not recruiting
  • Multiple Myeloma
    • Huntsville, Alabama
    • +252 more
    Jan 21, 2021

    Multiple Myeloma Trial in Chicago (Screening Phase, Discontinuation Phase)

    Recruiting
    • Multiple Myeloma
    • Screening Phase
    • Discontinuation Phase
    • Chicago, Illinois
      University Of Chicago Medicine Comprehensive Cancer Center
    Jan 8, 2021

    Multiple Myeloma, Renal Insufficiency Trial in Spain, United Kingdom, United States (BHQ880, BHQ880 Placebo, bortezomib)

    Completed
    • Multiple Myeloma
    • Renal Insufficiency
    • Chicago, Illinois
    • +7 more
    Dec 11, 2020

    Multiple Myeloma Trial in Worldwide (LGH447, midazolam)

    Completed
    • Multiple Myeloma
    • Chicago, Illinois
    • +7 more
    Dec 16, 2020